Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

Final 2023 physician fee schedule out from CMS; early reactions register exasperation, resolve

CMS has finalized the Medicare Physician Fee Schedule (MPFS) for 2023, and its reimbursement reductions for radiology are less harsh than those proposed preliminarily in July.

Cardiologists, electrophysiologists ‘disappointed’ in final 2023 Medicare Physician Fee Schedule

The American College of Cardiology and Heart Rhythm Society issued a joint statement soon after CMS published its final rule for the 2023 Medicare Physician Fee Schedule. The groups warned that the final rule could threaten patient access to high-quality care. 

files paperwork work load

CMS finalizes outpatient payment system

The final rule updated the OPPS payment rate by 3.8% for calendar year 2023, which CMS based on the 4.1% projected hospital market basket percentage increase and adjusted for 0.3 percentage points for productivity. 

 

Medicare money payment physician

CVS, Walgreens settle opioid lawsuits for $10B

CVS Health will pay $5 billion over the next 10 years, and Walgreens will pay $4.95 billion over the next 15 years.

Providers face ‘ominous reality’ of payment cuts as CMS finalizes 2023 Physician Fee Schedule

Physicians are now bracing for payment cuts after the Centers for Medicare and Medicaid Services (CMS) published its final rule for the 2023 Physician Fee Schedule.

Medicare money payment physician

AMA scrutinizes lack of competition, consumer harms in Medicare Advantage plans

Medicare Advantage plans face little in the way of competition, and Medicare consumers are worse off for it, according to a new study from the American Medical Association.

 

healthcare value value-based care money dollar

Johnson & Johnson to acquire Abiomed in $16.6B deal

Johnson & Johnson agreed to an upfront payment of $380 per share. Abiomed shareholders can also receive up to an additional $35 per share if certain milestones are met in the years ahead. 

Philips running short on MRI coil disposables, FDA advising providers to consider image-guidance alternatives

In a letter to providers, the agency recommends Philips clients in the affected product category consider any of three steps to cope with the interruption.